References
- CamilleriMBharuchaAEFarrugiaGEpidemiology, mechanisms, and management of diabetic gastroparesisClin Gastroenterol Hepatol20119151220951838
- ParkmanHPHaslerWLFisherRSAmerican Gastroenterological AssociationAmerican Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesisGastroenterology200412751589159115521025
- LacyBECrowellMDMathisCBauerDHeinbergLJGastroparesis: quality of life and health care utilizationJ Clin Gastroenterol2018521202427775961
- DiBaiseJKPatelNNoeltingJDueckACRoarkeMCrowellMDThe relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testingNeurogastroenterol Motil201628223424226547484
- PasrichaPJPehlivanovNSugumarAJankovicJDrug insight: from disturbed motility to disordered movement–a review of the clinical benefits and medicolegal risks of metoclopramideNat Clin Pract Gastroenterol Hepatol20063313814816511548
- CamilleriMParkmanHPShafiMAAbellTLGersonLAmerican College of GastroenterologyClinical guideline: management of gastroparesisAm J Gastroenterol20131081183723147521
- LemboACamilleriMMcCallumRRelamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesisGastroenterology20161511879627055601
- CamilleriMMcCallumRWTackJSpenceSCGottesdienerKFiedorekFTEfficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled studyGastroenterology201715351240125028760384
- RevickiDACamilleriMKuoBDevelopment and content validity of a gastroparesis cardinal symptom index daily diaryAliment Pharmacol Ther200930667068019558608
- RentzAMKahrilasPStanghelliniVDevelopment and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disordersQual Life Res200413101737174915651544
- FoodUSDrug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims2009 Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guid-ances/UCM193282.pdfAccessed July 25, 2017
- U.S. FoodDrug Administration. Gastroparesis: clinical evaluation of drugs for treatment. Guidance for industry2015 Available from: https://www.fda.gov/downloads/drugs/guidancecomplianceregulatory-information/guidances/ucm455645.pdfAccessed July 25, 2017
- NunnallyJCBernsteinIHPsychometric Theory3rd edNew YorkMcGraw-Hill1994
- CohenJA power primerPsychol Bull1992112115515919565683
- GuyattGWalterSNormanGMeasuring change over time: assessing the usefulness of evaluative instrumentsJ Chronic Dis19874021711783818871